167 related articles for article (PubMed ID: 16452585)
1. Montelukast improves regional air-trapping due to small airways obstruction in asthma.
Zeidler MR; Kleerup EC; Goldin JG; Kim HJ; Truong DA; Simmons MD; Sayre JW; Liu W; Elashoff R; Tashkin DP
Eur Respir J; 2006 Feb; 27(2):307-15. PubMed ID: 16452585
[TBL] [Abstract][Full Text] [Related]
2. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
Gao JM; Cai F; Peng M; Ma Y; Wang B
Chin Med J (Engl); 2013 Jun; 126(12):2229-34. PubMed ID: 23786930
[TBL] [Abstract][Full Text] [Related]
3. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast.
Kraft M; Cairns CB; Ellison MC; Pak J; Irvin C; Wenzel S
Chest; 2006 Dec; 130(6):1726-32. PubMed ID: 17166989
[TBL] [Abstract][Full Text] [Related]
4. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
6. Effect of montelukast on peripheral airflow obstruction in children with asthma.
Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
[TBL] [Abstract][Full Text] [Related]
7. Montelukast improves pulmonary function measured by impulse oscillometry in children with asthma (Mio study).
Nieto A; Pamies R; Oliver F; Medina A; Caballero L; Mazon A
Respir Med; 2006 Jul; 100(7):1180-5. PubMed ID: 16330196
[TBL] [Abstract][Full Text] [Related]
8. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
11. The effect of montelukast on bronchial hyperreactivity in preschool children.
Hakim F; Vilozni D; Adler A; Livnat G; Tal A; Bentur L
Chest; 2007 Jan; 131(1):180-6. PubMed ID: 17218573
[TBL] [Abstract][Full Text] [Related]
12. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Kelly MM; Chakir J; Vethanayagam D; Boulet LP; Laviolette M; Gauldie J; O'Byrne PM
Chest; 2006 Sep; 130(3):741-53. PubMed ID: 16963671
[TBL] [Abstract][Full Text] [Related]
13. Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing.
Ulrik CS; Diamant Z
Clin Exp Allergy; 2010 Apr; 40(4):576-81. PubMed ID: 20128823
[TBL] [Abstract][Full Text] [Related]
14. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
15. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
16. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
[TBL] [Abstract][Full Text] [Related]
17. A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics.
Currie GP; Lee DK; Dempsey OJ; Fowler SJ; Cowan LM; Lipworth BJ
Br J Clin Pharmacol; 2003 Jun; 55(6):609-15. PubMed ID: 12814457
[TBL] [Abstract][Full Text] [Related]
18. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast.
Bisgaard H; Loland L; Oj JA
Am J Respir Crit Care Med; 1999 Oct; 160(4):1227-31. PubMed ID: 10508811
[TBL] [Abstract][Full Text] [Related]
19. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM
Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
[TBL] [Abstract][Full Text] [Related]
20. Effect of a single dose of montelukast sodium on methacholine chloride PC20.
Davis BE; Cockcroft DW
Can Respir J; 2005; 12(1):26-8. PubMed ID: 15776131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
